US Inflammatory Bowel Disease (IBD) Market Expected to Rise at a CAGR of 9.3% during the Forecast Period from 2019 to 2025
The US IBD market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. factors such as the significant prevalence of IBD such as Crohn’s disease and ulcerative colitis across the country. As per the Centers for Disease Control and Prevention (CDC), the prevalence of Crohn’s disease and ulcerative colitis in the US was 201 and 238 per 100,000 population respectively in 2015. Moreover, the CDC also estimates the incidence rate of types of IBD across the country. As per the CDC, the incidence of Crohn’s disease and ulcerative colitis were nearly 14.6 and 14.3 per 100,000 population respectively in 2015. Additionally, according to the aforementioned organization, the percentage of people diagnosed with IBD (either Crohn’s disease or ulcerative colitis) increased from 0.9% of US adults in 1999 to 1.3% of US adults in 2015. This percentage is further expected to expand in the near future; thereby, promising significant growth for the IBD market during the forecast period.
To Request a Sample of our Report on US Inflammatory Bowel Disease (IBD) Market: https://www.omrglobal.com/request-sample/us-ibd-inflammatory-bowel-disease-market
US IBD market is segmented on the
basis of disease type, diagnostics, and therapeutics. US IBD market is
segmented on the basis of disease type into ulcerative colitis and Crohn’s
disease. Crohn’s disease segment is estimated to dominate the market. The growth
of the segment is attributed to the comparatively higher incidence of Crohn’s
disease than ulcerative colitis. On the basis of diagnostics, the market
segmented into blood and stool, endoscopies, ultrasound, and X-rays. Endoscopy
is a conventional diagnostic method that is widely being used for the diagnosis
of IBD and having a considerable share in the market. The therapeutics segment
is further segmented into anti-inflammatory drugs and surgery. There is a range
of anti-inflammatory drugs used for the treatment of IBD, such as
immunosuppressants (methotrexate, ciclosporin, and azathioprine), steroids and
biological drugs. These are usually the first step in the treatment of
IBD.
(Get 15% Discount on Buying this Report)
A
full Report of US Inflammatory Bowel Disease (IBD) Market is Available @ https://www.omrglobal.com/industry-reports/us-ibd-inflammatory-bowel-disease-market
US IBD Market Segmentation
By Disease Type
·
Ulcerative Colitis
·
Crohn’s Disease
By Diagnostics
·
Blood and Stool Tests
·
Endoscopies,
·
Ultrasound
·
X-Ray
By Therapeutics
·
Surgery
·
Anti- Inflammatory Drug Administration
·
Steroids
·
Immunosuppressant
·
Biological Drugs
·
Amino salicylates
·
Others
Company Profiles
·
Abbott Laboratories
·
AbbVie Inc.
·
Accesa Labs
·
Boehringer Ingelheim International GmbH
·
Celgene Corp.
·
Eli Lilly and Co.
·
Johnson & Johnson Services
Inc.
·
Laboratory Corporation of
America Holdings
·
Pfizer Inc.
·
Sanofi S.A.
·
Takeda pharmaceutical Co.,
Ltd.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment